Michael H. Carrel: 2025 was an exceptional year at AtriCure, Inc. with achievements across our business. This trial is evaluating the benefit of our AtriClip devices on non-AFib patients undergoing ...
Watsco (NYSE:WSO) executives told investors that the company exited fiscal 2025 with improved profitability, a strengthened balance sheet, and what management described as a more stable operating back ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results